Dual-Feed Payoff Is Real, but Q2 Will Strip Away the Windfall
Headline numbers soar (106% revenue, 1154% profit YoY), but Q1 saw PAT fall 2.8% QoQ despite higher volumes. The maize inventory benefit inflates margins by ₹9–10 per liter—a non-recurring tailwind that ends next quarter.
₹59.3 Cr
+1,154% YoY, -2.8% QoQ
~₹9–10/liter
Maize ₹18-22 vs. spot ₹25.50
~₹10–12
vs. ₹15–16 on lock-in
The tension: Headline growth masks margin compression
TruAlt reported a blowout: ₹626.9 Cr revenue (+106% YoY), ₹59.3 Cr PAT (+1,154% YoY). The day-1 market reaction was +2.62% delivery. On a 52-week chart, the pop held—day 5 still up +4.19%. But the call reveals the real story. Despite Q1 revenues rising 5.3% QoQ, PAT fell 2.8%. That gap—growth without leverage—tells you margin pressure is already here.
The culprit is inventory. TruAlt booked maize at ₹18–₹22 per kg when it was cheaper. That stock is now valued against a spot price of ₹25.50/kg—a ₹9–₹10 per liter margin benefit that is non-recurring. Once the dual-feed plants cycle through that inventory (expected Q2), normalized maize cost yields only ₹6–₹7 per liter margin, versus the ₹15–₹16 the quarter is banking on. Employee cost additions (180 CBG hires) and a ₹11 Cr finance drag absorbed the volume uplift.
Revenue close to ₹630 Cr, ethanol 8.5 Cr liters produced
₹626.9 Cr revenue, 8.5 Cr liter sales guidance matched
Supported
44 Cr liters orders on hand for FY27
44 Cr liters confirmed; 55 Cr capacity target implied 80% conversion, not a miss
Supported (but partial guidance)
Grain-based feedstock 6% margin better than sugar
Confirmed: grain ₹314 Cr vs. sugar ₹277 Cr on similar volume; 50:50 blend this Q
Supported
CBG 40–50% PAT margin at 78% utilization
CBG ₹11.2 Cr revenue, ₹5.1 Cr PBT = 45.5% margin; 1x maintenance cost cited
Supported
15 Cr liter court case implementation imminent
MD: 'still stands open, making all efforts' but no timeline disclosed
Unresolved—not in base 44 Cr guidance
What changed on this call
Dual-feed transition complete: 3 of 5 plants on grain blend; 6% margin lift realized
CBG capex accelerated: 132 TPD new capacity by Q4 FY27 (vs. FY28 prior), ₹760 Cr gross, 70:30 debt
Maize cost trajectory deteriorated: ₹25.50/kg spot vs. ₹22–24 normalized; Q2 headwind ₹9–10/liter
Fuel retail expansion stalled: 76 outlets identified, 7 live, 4 in pipeline; deferred due to Middle East crude volatility
Guidance maintained (55 Cr liters ethanol, CBG, SAF capex), not raised; implicit 44 Cr order base vs. capacity target
The bull-bear ledger
Dual-feed economics proven: grain margin 6% better than sugar; yield 450 vs. 317; co-product DDGS ₹47 Cr upside
CBG pilot validated: 45.5% PAT margin, 78% utilization; JV capex accelerated to Q4 revenue start
44 Cr liters orders provide visibility; OMC + private + ENA channels diversified
Reported PAT soared (+1,154% YoY) but Q1 QoQ fell 2.8% despite 5.3% revenue growth—no leverage materializing
Inventory margin benefit ₹9–10/liter non-recurring; normalized maize ₹6–7/liter hits Q2
Only 44 Cr liters (80% capacity) vs. 55 Cr target; 15 Cr liter court case unresolved—tender allocation risk
Finance cost ₹44 Cr annualized (₹11 Cr this Q) = 7% of revenue; de-leverage plan pending, not disclosed
CBG policy in flux: MDA (fertilizer subsidy) dependence for FOM monetization; Sampoorna program rollout uncertain
SAF adoption uncertain: ₹2,000 Cr capex, FY29 revenue, ₹180–200/liter price = 1.8x ATF; airline cost sensitivity high
Risks, ranked by how much they should concern a holder
Inventory margin windfall fades Q2
HighMaize ₹18–22 lock-in realizing ₹15–16/liter margin; spot ₹25.50 yields ₹6–7/liter. Q2 procurement headwind ₹9–10/liter. Strip away the benefit and adjusted EBITDA margin falls to 16–18% from Q1's 23.5%.
Tender allocation fairness (44 Cr vs. 55 Cr capacity)
HighOnly 80% utilization on filed capacity. MD flagged 'unfair means' in prior allocation. Sept–Oct new ethanol bidding cycle critical. If 44 Cr holds, FY27 revenue tops out ~₹3,000 Cr (vs. ₹3,700 Cr at full capacity).
Maize cost volatility
HighAt ₹22–24/kg (normalized), margins ₹10–12/liter; locked-in benefit ₹9–10/liter masks Q2 pressure. Spot ₹25.50 already compresses to ₹6–7/liter. Policy change or global supply shock could extend the pain.
Finance cost burden
Medium-High₹44 Cr annualized (₹11 Cr Q1) on ₹626.9 Cr revenue = 7% drag. DSCR 1.36x leaves little margin for rate shocks. De-leverage plan exists but not disclosed. At current leverage, FCF available for capex or buyback is constrained.
CBG policy flux (MDA subsidy, Sampoorna rollout)
MediumCBG 40–50% PAT margins dependent on FOM monetization at ₹2,500–2,800/ton. MDA (fertilizer subsidy) under review; Sampoorna program coming with 'multiple corrections.' If subsidy cut, FOM realization falls, margin to 25–35% PBT. JV capex (₹760 Cr) is at risk if returns fall.
15 Cr liter court case unresolved
MediumNot in base 44 Cr guidance. If it resolves, adds ~₹1,000 Cr incremental FY27 revenue and materially raises PAT. If it doesn't, upside story breaks. No timeline disclosed.
SAF adoption and pricing uncertainty
Medium₹2,000 Cr capex for FY29 revenue is contingent on airline willingness to pay ₹180–200/liter (1.8x ATF). Carbon benefit alone may not drive adoption without mandates. EPC bidding in 2–3 months; execution risk high.
How the street is positioned
Post-result price action confirms the market believes the story, for now. The day-1 pop of +2.62% (from ₹419.15 pre-result) held—by day 5 the stock was up +4.19%. That tells you institutional buyers saw the dual-feed transition and CBG acceleration as credible, not a one-quarter fluke. Volume was normal, not climactic.
But valuation and positioning show cracks. The stock is at ₹481.6, -11.14% from its all-time high of ₹542. It's trading above its SMA20 (₹446.52), SMA50 (₹460.83), and SMA200 (₹433.48)—a classic uptrend. Yet RSI is 72.4 (overbought), and momentum could fade if Q2 earnings quality deteriorates.
Institutional flows are trimming, not adding. FII ownership fell 0.08 percentage points QoQ (0.58% now vs. 0.66% prior); DII fell 1.04pp (8.36% now vs. 9.40% prior). That's not a rout, but it's not conviction buying either. The June bulk deals show retail/prop activity (₹516–₹506/share range), but no promoter insider buying at these levels—a yellow flag.
The market's verdict is cautiously bullish on the decade-long structural story (ethanol blending, CBG policy tailwinds, SAF early-mover edge) but wary of the next quarter's earnings quality. That's a reasonable read.
The debate
What to watch next
1 · Q2 FY27 sales and EBITDA margin (next quarter)
Management guided 11–12 Cr liter sales. The acid test: does EBITDA margin hold above 20% without the inventory windfall, or does it compress to 16–18%? Maize cost trajectory (is it stabilizing or staying elevated at ₹25+/kg?) will answer this. If normalized, adjusted EBITDA margin validates the dual-feed thesis at ₹10–12/liter. If not, the bear case wins.
2 · CBG JV first revenues (Q4 FY27, Sep–Dec 2026)
3 Sumitomo plants + 6 GAIL plants (132 TPD total, 51% TruAlt ownership) expected to generate revenue by Q4. Key metrics: utilization (60% Y1 assumed), FOM realization (₹2,500–2,800/ton current, ₹6,000 target), gas pricing (₹84/kg static). If CBG PAT margin falls below 40% at 70%+ utilization, policy risk (MDA/Sampoorna) is real and de-rates capex returns.
3 · Tender allocation fairness (Sept–Oct 2026, next bidding cycle)
The new ethanol allocation cycle will tell you if 44 Cr liters was a low-ball due to 'unfair means' or a structural ceiling. If TruAlt secures 50+ Cr liters, the court case upside becomes less critical. If it stays at 44 Cr (or lower), tender allocation risk is embedded and FY27 revenue tops out ~₹3,000 Cr.
4 · 15 Cr liter court case resolution (timing TBD)
If implemented, adds ~₹1,000 Cr revenue upside (at ₹67/liter). PAT upside ₹100–150 Cr (at 12–15% margin). This is optionality, not base case. No timeline, so price it at <50% probability. Resolution or closure would materially de-risk the guidance and validate the bull case.
5 · De-leverage plan disclosure
MD dodged this on the call. Finance cost ₹44 Cr annualized is high relative to EBITDA ₹147 Cr (30% of EBITDA). If management commits to de-leverage (refinancing, asset sales, equity raise), it signals confidence in cash generation. Absence of a plan by Q2 call is a negative signal.
6 · SAF capex progress (next 2–3 months, FEED completion)
EPC bidding underway. Land procurement from Andhra Pradesh state. If execution slips (common on ₹2,000 Cr capex), FY29 revenue timeline at risk. Early wins (binding MOUs with airlines, finalized capex budget) would de-risk the story.
The verdict
Credibility grade: B. Management hit Q1 revenue and PAT targets disclosed in the CFO deck (₹625+ Cr, ₹59+ Cr). Guided 55 Cr liters ethanol capacity and CBG, SAF expansion timelines have not moved. Shortfall: 44 Cr liters orders (80% of capacity target) vs. 55 Cr full-year run-rate; 15 Cr liter court case remains unresolved with no formal timeline; Q1 QoQ PAT compression despite revenue growth signals margins softer than expected. Not a trust breach, but a reminder that the next two quarters are execution tests, not confirmation rallies.
TruAlt's dual-feed transition is real, and the economics (6% margin lift on grain vs. sugar) are proven. CBG capex and SAF ambitions are credible for a mid-sized biofuels player with government backing. But Q1's reported profit is inflated by an inventory benefit that fades in Q2. Tender allocation to 80% of capacity (44 Cr vs. 55 Cr liters) and unresolved court case add risk. The honest read is steady, disciplined capital deployment, not a breakout. Finance cost (₹44 Cr annualized) is material and unsustainable without de-leverage. The market's post-result rally (+4.19% by day 5) was justified but is now overbought (RSI 72.4). Conviction lies in Q2 earnings quality: if normalized maize cost (₹22–24/kg) and tender allocation dynamics hold firm, adjusted EBITDA margin (ex-inventory benefit) will stabilize around 18–20%, validating the dual-feed case. If not, downside to ₹420–440 is likely. The number to track is adjusted EBITDA margin per liter—it's the true measure of earnings power.
Informational and educational content only. Not investment advice.